Developer docs
API playgroundTry for free, no card

Search company profiles

STATinMED

Full company profile

uuid0005ngj

Namestring
STATinMED
Legal namestring
STATinMED LLC
Websiteurl
statinmed.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

STATinMED is a Dallas-based, privately held LLC (founded 2007, 51–100 employees) operating as a real-world evidence (RWE) and health economics and outcomes research (HEOR) consultancy for healthcare and life science companies. Its core technology is STATinMED RWD Insights, a proprietary all-payer medical and pharmacy claims database sourced from clearinghouses, covering approximately 80% of the US healthcare system across 300+ million patient lives (commercial, Medicaid, Medicare FFS, and Medicare Advantage), updated monthly with a 15-day lag. In 2022 the firm extended this asset into two productized offerings — RWD Custom Registry (configurable patient-level data with time-varying metrics) and RWD Insights Direct (a branded platform for client-side data capability augmentation) — and serves clients including 22 of the Top 25 global pharmaceutical companies, with over 1,000 peer-reviewed publications across 20+ therapeutic areas and 150+ indications.

The company monetizes through professional services (HEOR, Market Access, Clinical Operations, Medical Affairs, Data Advisory, and peer-reviewed publication services) delivered via project-based engagements and direct consultative sales, supplemented by what appears to be recurring/subscription access to its RWD Insights data products. Pricing is quote-based and not publicly disclosed; the GTM motion is enterprise field sales with complimentary consultations and customized study designs. Customer segments include primary biopharmaceutical companies and secondary life-science and broader healthcare organizations, with horizontal segmentation across use cases (evidence generation, market access, clinical operations, medical affairs).

STATinMED operates under HIPAA-compliant, de-identified and tokenized data practices and has adopted GDPR controller obligations, positioning it for cross-border engagements. Marketing channels span content (peer-reviewed publications, blog), events (16+ major medical conferences annually including ISPOR, ASH, AHA, ESC), and owned social/email channels (LinkedIn, Twitter, YouTube, quarterly newsletters). Leadership includes a President (Jason Drenning, PhD), Vice Presidents for RWE (Maxine Fisher, PhD), Strategic Initiatives (Mike Rials, MS), and Finance (John Sommerhalder), plus a Senior Principal for Strategic Advisory Services. No external institutional investment, PE, or VC backing is evident, and revenue is not publicly disclosed.

Short descriptiontext

STATinMED is a Dallas-based healthcare consultancy (founded 2007) that provides real-world evidence and HEOR services to biopharmaceutical companies using a proprietary all-payer claims database covering ~80% of the US healthcare system.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDallas, United States
HQ citystring
Dallas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
real-world evidence, health economics research, outcomes research consulting, market access strategy, pharmaceutical data analytics
Industry5 codes
PRIMARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
SECONDARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYHLACAIAJ
Real-World Data (RWD) Platforms & Clinical Data Curation
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLAIALAI
Real-World Evidence (RWE) & HEOR for Development
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Other Scientific and Technical Consulting Services54169
SIC code2 codes
  • Services-Misc Health & Allied Services, Nec8090
  • Services-Medical Laboratories8071
Product category
Healthcare Real-World Evidence and HEOR Consulting
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Real-World Evidence Consulting Services
TypeProfessional Services
Description

Professional consulting services providing real-world evidence generation, HEOR analysis, market access support, and strategic advisory services to healthcare and life science companies. Services are customized based on client research needs and delivered through project-based engagements.

statinmed.com
2Data Access and Insights
TypeSubscription Recurring
Description

Access to RWD Insights database and custom registry data products for evidence generation. Provides data lake advisory services to help clients develop ideal data infrastructure aligned with research goals.

statinmed.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1RWD Insights
Description

STATinMED's robust, licensed all-payer medical and pharmacy claims real-world data source covering over 80% of the US healthcare system

statinmed.com
+2 more records
Core offering1 text field

STATinMED delivers real-world evidence (RWE) consulting and proprietary all-payer medical and pharmacy claims data to pharmaceutical and life science companies. Its flagship offering combines the RWD Insights database (covering ~80% of the US healthcare system and 300+ million patient lives) with HEOR, Market Access, Clinical Operations, Medical Affairs, Data Advisory, and Peer-Reviewed Publication services. Engagements are customized to client research needs and delivered as project-based professional services engagements alongside licensed data access.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Captures approximately 80% of all US claims including medical and pharmacy across commercial, Medicaid & Medicare channels
+2 more records
Product overview1 text field

STATinMED is a real-world evidence company offering a unified portfolio centered on its STATinMED RWD Insights data platform. The core offering includes the RWD Insights all-payer medical and pharmacy claims database covering over 300 million patient lives, supplemented by the RWD Custom Registry for tailored patient registries and RWD Insights Direct for enhanced analytics capabilities. The company provides a comprehensive suite of services including HEOR (Health Economics and Outcomes Research), Market Access, Clinical Operations Support, Medical Affairs Support, Data Advisory Services, and Peer-Reviewed Publication Services. Together, these products and services enable life science companies to discover real-world data, develop evidence-based insights, and deliver value through the product lifecycle from Phase II/III through post-launch.

Product and service9 records
1STATinMED RWD Insights
CategoryReal-world data platform
Description

Licensed all-payer medical and pharmacy claims real-world data platform capturing over 80% of the US healthcare system (300+ million patient lives), sourced from claims clearinghouses across all 50 states and updated monthly with a ~15-day delay. Licensed to healthcare and life science companies for real-world evidence generation.

2RWD Custom Registry
CategoryReal-world data product
Description

Actionable, research-ready patient-level data product providing insights about patients with any disease and their treatment journey, including demographics, comorbidities, HCRU and costs, treatment utilization, HCP specialty, payer account, and time-varying metrics. Licensed to healthcare and life sciences clients for evidence generation.

3RWD Insights Direct
CategoryReal-world data analytics platform
Description

Product offering designed to help healthcare companies enhance their real-world data capabilities, providing robust business intelligence from a team of analysts who understand client goals, delivered alongside a dedicated online portal.

4HEOR Services
CategoryConsulting service
Description

Health Economics and Outcomes Research services supporting product value demonstration from Phase II/III through post-launch, including unmet needs discovery, disease landscape mapping, epidemiology support, burden of illness measurement, comparative effectiveness, and value communication for pharmaceutical and life sciences clients.

5Market Access Services
CategoryConsulting service
Description

Data insights for product launch through commercialization, including clinical eligibility assessment, HCO-HCP insights, opportunity loss measurement, competitive indication share analysis, and payer-provider prioritization for pharmaceutical clients.

6Clinical Operations Support
CategoryConsulting service
Description

Services for clinical trial teams including study design prioritization and optimization, trial feasibility assessment, and patient and site selection using actionable, research-ready real-world data.

7Medical Affairs Support
CategoryConsulting service
Description

Accelerated safety assessments and regulatory response support leveraging curated real-world evidence insights to produce faster, more accurate outcomes for pharmaceutical medical affairs teams.

8Data Advisory Services
CategoryConsulting service
Description

Advisory and linkage services helping clients develop ideal data lakes sourced with curated data aligned with research goals, including data source identification, feasibility assessment, and analysis for healthcare companies.

9Peer-Reviewed Publication Services
CategoryConsulting service
Description

Writing and editing services for abstracts, posters, manuscripts, and presentations delivered by STATinMED's research team, with a track record of over 1,000 peer-reviewed publications across dozens of therapeutic areas.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Strategy and RWE consultancy focused on biopharma evidence generation, market access and launch. Comparable customer base, project-based delivery, and thought-leadership-driven marketing.

TypeDirect peer
Description

Data analytics and RWE firm serving pharma with proprietary data assets, HEOR, and commercial analytics. Comparable combination of consulting and productized data offerings, but at significantly larger scale.

TypeBroad incumbent
Description

Global CRO offering RWE, HEOR and real-world data services alongside clinical operations. Competes for the same Top-25 pharma evidence-generation budgets and sponsors, with comparable full-lifecycle positioning.

TypeEmerging player
Description

Healthcare data platform layering de-identified patient journeys over US payer and provider data. Comparable to RWD Insights in dataset scope, but productized as software vs STATinMED's services-led delivery.

TypeBroad incumbent
Description

Largest global CRO and RWE platform with proprietary IQVIA claims, EHR and registry data. Directly comparable as a one-stop competitor for STATinMED's pharma RWE and HEOR engagements, but far larger and embedded across clinical and commercial.

TypeDirect peer
Description

Pure-play HEOR, market access and RWE consulting firm (now part of PPD/Thermo Fisher). Closest comparable to STATinMED in service mix, therapeutic breadth, and publication-led go-to-market.

TypeBroad incumbent
Description

Established US claims and patient-level data provider for pharma RWE and commercial analytics. Direct substitute for STATinMED's all-payer claims data use case from the buyer perspective.

TypeDirect peer
Description

Data-driven health marketing, RWE and consulting firm working with pharma and life sciences. Overlaps with STATinMED in RWE analytics, healthcare AI applications, and biopharma client base.

TypeEmerging player
Description

Commercial intelligence and analytics platform over healthcare provider, claims and affiliation data. Adjacent competitor for the 'data + insights' wedge of STATinMED's portfolio with biopharma commercial users.

TypeBroad incumbent
Description

Owns one of the largest US commercial and Medicare claims data assets and serves biopharma with RWE, HEOR and market access services. Direct analogue to STATinMED's RWD Insights use cases, with far deeper payer integration.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

STATinMED

Healthcare Real-World Evidence and HEOR Consultingstatinmed.com

STATinMED is a Dallas-based healthcare consultancy (founded 2007) that provides real-world evidence and HEOR services to biopharmaceutical companies using a proprietary all-payer claims database covering ~80% of the US healthcare system.

What STATinMED does

STATinMED is a Dallas-based, privately held LLC (founded 2007, 51–100 employees) operating as a real-world evidence (RWE) and health economics and outcomes research (HEOR) consultancy for healthcare and life science companies. Its core technology is STATinMED RWD Insights, a proprietary all-payer medical and pharmacy claims database sourced from clearinghouses, covering approximately 80% of the US healthcare system across 300+ million patient lives (commercial, Medicaid, Medicare FFS, and Medicare Advantage), updated monthly with a 15-day lag. In 2022 the firm extended this asset into two productized offerings — RWD Custom Registry (configurable patient-level data with time-varying metrics) and RWD Insights Direct (a branded platform for client-side data capability augmentation) — and serves clients including 22 of the Top 25 global pharmaceutical companies, with over 1,000 peer-reviewed publications across 20+ therapeutic areas and 150+ indications.

The company monetizes through professional services (HEOR, Market Access, Clinical Operations, Medical Affairs, Data Advisory, and peer-reviewed publication services) delivered via project-based engagements and direct consultative sales, supplemented by what appears to be recurring/subscription access to its RWD Insights data products. Pricing is quote-based and not publicly disclosed; the GTM motion is enterprise field sales with complimentary consultations and customized study designs. Customer segments include primary biopharmaceutical companies and secondary life-science and broader healthcare organizations, with horizontal segmentation across use cases (evidence generation, market access, clinical operations, medical affairs).

STATinMED operates under HIPAA-compliant, de-identified and tokenized data practices and has adopted GDPR controller obligations, positioning it for cross-border engagements. Marketing channels span content (peer-reviewed publications, blog), events (16+ major medical conferences annually including ISPOR, ASH, AHA, ESC), and owned social/email channels (LinkedIn, Twitter, YouTube, quarterly newsletters). Leadership includes a President (Jason Drenning, PhD), Vice Presidents for RWE (Maxine Fisher, PhD), Strategic Initiatives (Mike Rials, MS), and Finance (John Sommerhalder), plus a Senior Principal for Strategic Advisory Services. No external institutional investment, PE, or VC backing is evident, and revenue is not publicly disclosed.

STATinMED firmographics

Firmographics
Name
STATinMED
Legal name
STATinMED LLC
Website
https://statinmed.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Short description
STATinMED is a Dallas-based healthcare consultancy (founded 2007) that provides real-world evidence and HEOR services to biopharmaceutical companies using a proprietary all-payer claims database covering ~80% of the US healthcare system.
Ownership category
akta.pro rank

STATinMED industry classification

Industry
Product category
Healthcare Real-World Evidence and HEOR Consulting
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Misc Health & Allied Services, Nec (8090), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
SECONDARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYHLACAIAJ
Real-World Data (RWD) Platforms & Clinical Data Curation
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLAIALAI
Real-World Evidence (RWE) & HEOR for Development
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Real-world evidence
  • Health economics research
  • Outcomes research consulting
  • Market access strategy
  • Pharmaceutical data analytics

Where STATinMED is headquartered

Location

Headquarters

HQ city
Dallas
HQ country
United States
HQ region
North America

Offices1 record

Markets served

STATinMED business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Real-World Evidence Consulting Services: Professional consulting services providing real-world evidence generation, HEOR analysis, market access support, and strategic advisory services to healthcare and life science companies. Services are customized based on client research needs and delivered through project-based engagements.
  2. Data Access and Insights: Access to RWD Insights database and custom registry data products for evidence generation. Provides data lake advisory services to help clients develop ideal data infrastructure aligned with research goals.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

STATinMED product offering

Product offering

Core offering

STATinMED delivers real-world evidence (RWE) consulting and proprietary all-payer medical and pharmacy claims data to pharmaceutical and life science companies. Its flagship offering combines the RWD Insights database (covering ~80% of the US healthcare system and 300+ million patient lives) with HEOR, Market Access, Clinical Operations, Medical Affairs, Data Advisory, and Peer-Reviewed Publication services. Engagements are customized to client research needs and delivered as project-based professional services engagements alongside licensed data access.

Product overview

STATinMED is a real-world evidence company offering a unified portfolio centered on its STATinMED RWD Insights data platform. The core offering includes the RWD Insights all-payer medical and pharmacy claims database covering over 300 million patient lives, supplemented by the RWD Custom Registry for tailored patient registries and RWD Insights Direct for enhanced analytics capabilities. The company provides a comprehensive suite of services including HEOR (Health Economics and Outcomes Research), Market Access, Clinical Operations Support, Medical Affairs Support, Data Advisory Services, and Peer-Reviewed Publication Services. Together, these products and services enable life science companies to discover real-world data, develop evidence-based insights, and deliver value through the product lifecycle from Phase II/III through post-launch.

Differentiator

Problem solved

Functional benefit

Brands

  • RWD Insights: STATinMED's robust, licensed all-payer medical and pharmacy claims real-world data source covering over 80% of the US healthcare system
  • RWD Custom Registry
  • RWD Insights Direct

Products and services

  • STATinMED RWD Insights Licensed all-payer medical and pharmacy claims real-world data platform capturing over 80% of the US healthcare system (300+ million patient lives), sourced from claims clearinghouses across all 50 states and updated monthly with a ~15-day delay. Licensed to healthcare and life science companies for real-world evidence generation.
  • RWD Custom Registry Actionable, research-ready patient-level data product providing insights about patients with any disease and their treatment journey, including demographics, comorbidities, HCRU and costs, treatment utilization, HCP specialty, payer account, and time-varying metrics. Licensed to healthcare and life sciences clients for evidence generation.
  • RWD Insights Direct Product offering designed to help healthcare companies enhance their real-world data capabilities, providing robust business intelligence from a team of analysts who understand client goals, delivered alongside a dedicated online portal.
  • HEOR Services Health Economics and Outcomes Research services supporting product value demonstration from Phase II/III through post-launch, including unmet needs discovery, disease landscape mapping, epidemiology support, burden of illness measurement, comparative effectiveness, and value communication for pharmaceutical and life sciences clients.
  • Market Access Services Data insights for product launch through commercialization, including clinical eligibility assessment, HCO-HCP insights, opportunity loss measurement, competitive indication share analysis, and payer-provider prioritization for pharmaceutical clients.
  • Clinical Operations Support Services for clinical trial teams including study design prioritization and optimization, trial feasibility assessment, and patient and site selection using actionable, research-ready real-world data.
  • Medical Affairs Support Accelerated safety assessments and regulatory response support leveraging curated real-world evidence insights to produce faster, more accurate outcomes for pharmaceutical medical affairs teams.
  • Data Advisory Services Advisory and linkage services helping clients develop ideal data lakes sourced with curated data aligned with research goals, including data source identification, feasibility assessment, and analysis for healthcare companies.
  • Peer-Reviewed Publication Services Writing and editing services for abstracts, posters, manuscripts, and presentations delivered by STATinMED's research team, with a track record of over 1,000 peer-reviewed publications across dozens of therapeutic areas.

Quantifiable outcome

  • Captures approximately 80% of all US claims including medical and pharmacy across commercial, Medicaid & Medicare channels
  • +2 more outcomes

Companies that use STATinMED

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

STATinMED technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

STATinMED partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

STATinMED competitors and assessment

Company assessment

Direct peers

  • Trinity Life Sciences: Strategy and RWE consultancy focused on biopharma evidence generation, market access and launch. Comparable customer base, project-based delivery, and thought-leadership-driven marketing.
  • Axtria: Data analytics and RWE firm serving pharma with proprietary data assets, HEOR, and commercial analytics. Comparable combination of consulting and productized data offerings, but at significantly larger scale.
  • Evidera: Pure-play HEOR, market access and RWE consulting firm (now part of PPD/Thermo Fisher). Closest comparable to STATinMED in service mix, therapeutic breadth, and publication-led go-to-market.
  • Real Chemistry: Data-driven health marketing, RWE and consulting firm working with pharma and life sciences. Overlaps with STATinMED in RWE analytics, healthcare AI applications, and biopharma client base.

Broad incumbents

  • ICON plc: Global CRO offering RWE, HEOR and real-world data services alongside clinical operations. Competes for the same Top-25 pharma evidence-generation budgets and sponsors, with comparable full-lifecycle positioning.
  • IQVIA: Largest global CRO and RWE platform with proprietary IQVIA claims, EHR and registry data. Directly comparable as a one-stop competitor for STATinMED's pharma RWE and HEOR engagements, but far larger and embedded across clinical and commercial.
  • Symphony Health (an ICON company): Established US claims and patient-level data provider for pharma RWE and commercial analytics. Direct substitute for STATinMED's all-payer claims data use case from the buyer perspective.
  • Optum (UnitedHealth Group): Owns one of the largest US commercial and Medicare claims data assets and serves biopharma with RWE, HEOR and market access services. Direct analogue to STATinMED's RWD Insights use cases, with far deeper payer integration.

Emerging players

  • Komodo Health: Healthcare data platform layering de-identified patient journeys over US payer and provider data. Comparable to RWD Insights in dataset scope, but productized as software vs STATinMED's services-led delivery.
  • Definitive Healthcare: Commercial intelligence and analytics platform over healthcare provider, claims and affiliation data. Adjacent competitor for the 'data + insights' wedge of STATinMED's portfolio with biopharma commercial users.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

STATinMED social profiles

Digital presence

STATinMED compliance and trust

Trust signal

Compliance3 records

STATinMED financial estimates

Financial estimate

Revenue estimate

Valuation estimate

STATinMED leadership team

Management profile

Number of profiles

Profiles5 records

STATinMED funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

STATinMED M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about STATinMED

What does STATinMED do?

STATinMED delivers real-world evidence (RWE) consulting and proprietary all-payer medical and pharmacy claims data to pharmaceutical and life science companies. Its flagship offering combines the RWD Insights database (covering ~80% of the US healthcare system and 300+ million patient lives) with HEOR, Market Access, Clinical Operations, Medical Affairs, Data Advisory, and Peer-Reviewed Publication services. Engagements are customized to client research needs and delivered as project-based professional services engagements alongside licensed data access.

Is STATinMED a public or private company?

STATinMED is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was STATinMED founded?

STATinMED was founded in 2007. It employs 11 to 50 people.

Where is STATinMED based?

STATinMED is headquartered in Dallas, United States, in the North America region.

How does STATinMED make money?

Two revenue lines are on record. Real-World Evidence Consulting Services are the primary driver. The others are data Access and Insights.

Who are STATinMED's main competitors?

Direct peers on record are Trinity Life Sciences, Axtria, Evidera and Real Chemistry. Broad incumbents are ICON plc, IQVIA, Symphony Health (an ICON company) and Optum (UnitedHealth Group). Emerging players are Komodo Health and Definitive Healthcare.

Does STATinMED have an API?

No public API is recorded for STATinMED.

What industry is STATinMED in?

STATinMED's product category is Healthcare Real-World Evidence and HEOR Consulting. Its primary akta.pro industry code is BPAHALAN, Healthcare Outcomes & Real-World Evidence (RWE) Analytics, with a secondary code of HLAGAAAK, Real-World Evidence (RWE), HEOR & Epidemiology CROs. Its NAICS code is 54171 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales